Each visit reviews symptom response, side effects, injection-site tolerance, and adjusts dose if indicated
Vogiatzoglou A, Oulhaj A, Smith AD, Nurk E, Drevon CA, Ueland PM, Vollset SE, Tell GS, Refsum H
Why are BPC-157 and TB-500 often studied together
The FDA classifies it as a Category 2 bulk drug substance, noting potential safety concerns in unregulated compounding
Research in rats investigated whether duodenal lesions induced by major venous occlusions can be reduced by BPC 157 peptide regardless nitric oxide (NO) system participation, and came to conclusion, that the peptide quickly avoided occlusion, and could rescue the original duodenal flow
It is always best to follow the instructions provided with the peptide for exact measurements